Correction to: Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review (Advances in Therapy, (2018), 35, 12, (2224-2235), 10.1007/s12325-018-0832-8)

Research output: Contribution to journalComment/debateResearch

Abstract

Unfortunately the funding information is incorrect in the published article. The correct funding information is ‘‘No funding or sponsorship was received for this study. EVER Pharmaceuticals funded the article processing charges and open access fee’’.

Original languageEnglish
JournalAdvances in Therapy
DOIs
StatePublished - 2019 Jan 1

Fingerprint

Fees and Charges
Subarachnoid Hemorrhage
Pharmaceutical Preparations
Therapeutics
cerebrolysin

Cite this

@article{0541ea8e6e5343f3913eeeabb8d96ef2,
title = "Correction to: Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review (Advances in Therapy, (2018), 35, 12, (2224-2235), 10.1007/s12325-018-0832-8)",
abstract = "Unfortunately the funding information is incorrect in the published article. The correct funding information is ‘‘No funding or sponsorship was received for this study. EVER Pharmaceuticals funded the article processing charges and open access fee’’.",
author = "Park, {Yung Ki} and Hyeong-Joong Yi and Choi, {Choi Kyu-Sun} and Young-Jun Lee and Kim, {Dong Won} and Kwon, {Sae Min}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12325-019-00930-9",
language = "English",
journal = "Advances in Therapy",
issn = "0741-238X",

}

TY - JOUR

T1 - Correction to

T2 - Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review (Advances in Therapy, (2018), 35, 12, (2224-2235), 10.1007/s12325-018-0832-8)

AU - Park, Yung Ki

AU - Yi, Hyeong-Joong

AU - Choi, Choi Kyu-Sun

AU - Lee, Young-Jun

AU - Kim, Dong Won

AU - Kwon, Sae Min

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Unfortunately the funding information is incorrect in the published article. The correct funding information is ‘‘No funding or sponsorship was received for this study. EVER Pharmaceuticals funded the article processing charges and open access fee’’.

AB - Unfortunately the funding information is incorrect in the published article. The correct funding information is ‘‘No funding or sponsorship was received for this study. EVER Pharmaceuticals funded the article processing charges and open access fee’’.

UR - http://www.scopus.com/inward/record.url?scp=85063278973&partnerID=8YFLogxK

U2 - 10.1007/s12325-019-00930-9

DO - 10.1007/s12325-019-00930-9

M3 - Comment/debate

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

ER -